Baltimore entrepreneur looks to raise $500K to launch first medical product
A Baltimore medical device startup is seeking $500,000 in funding and U.S. Food and Drug Administration approval, so it can market a new spray that can help stop someone from bleeding out.
BC3 Technologies, a medical device firm, is looking to commercialize its first product, called SEAL. It is an aerosolized hemostatic, or spray that can help induce clotting and stop a wound from bleeding, buying someone extra time to get to a hospital for treatment. The company recently completed a three-month…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news
More News: Bleeding | Food and Drug Administration (FDA) | Funding | Health Management | Hospitals | Medical Devices | Pharmaceuticals